Loading...
Please wait, while we are loading the content...
Similar Documents
Toward the Rapid Treatment of Depression by Selective Inhibition of Central Stress Circuits
| Content Provider | Semantic Scholar |
|---|---|
| Author | Stone, Eric A. Lin, Yan Sarfraz, Yasmeen |
| Copyright Year | 2012 |
| Abstract | A long standing problem with antidepressant drugs is their delayed onsets of action which has made them unsatisfactory in the rapid treatment of serious depressions involving agitated and suicidal behavior. Two new approaches to this problem involve the glutamatergic antagonist, ketamine, recently reviewed, and the acute inhibition of central stress circuits, which is the subject of the present review. The rationale behind stress-circuit inhibition comes from the findings that both clinical and experimental depressions are accompanied by increased neural activity in the stress network together with inhibited activity in regions underlying active motivated behaviors, and that both changes are reversed by effective antidepressant treatment. It has been shown further that direct pharmacological inhibition of central noradrenergic stress nuclei produces immediate reversal of depressive-like passive as well as sickness behaviors. Dipivalyl-6-fluoronorepinephrine (dp6FNE), a brain-permeable pro-drug of 6FNE, a full agonist at inhibitory brain adrenoceptors in brainstem noradrenergic stress nuclei, has been developed and found in preliminary studies to cause rapid reversal of both passivity and anhedonia as well as anxiolysis without significant hypoactivity in the open field. Low doses of agonists of glucocorticoid and 5HT1A autoreceptors, which respectively inhibit the hypothalamic-pituitaryadrenal axis and serotonergic stress systems, may also share these effects as well as potentiate the actions of dp6FNE. Anti-stress effects may also be involved in the rapid therapeutic effects found with intracerebral administration of first generation antidepressants and may prove helpful in potentiating the therapeutic actions of stimulants. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://benthamopen.com/contents/pdf/TONEUROPPJ/TONEUROPPJ-5-9.pdf |
| Alternate Webpage(s) | http://www.bentham-open.com/contents/pdf/TONEUROPPJ/TONEUROPPJ-5-9.pdf |
| Alternate Webpage(s) | https://benthamopen.com/contents/pdf/TONEUROPPJ/TONEUROPPJ-5-9.pdf |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Adrenergic Receptor Agitation Anhedonia Antidepressive Agents Apache Axis Autoreceptors Axis vertebra Brain Stem Depressive disorder Design rationale Illness Behavior Ketamine Land administration Pharmacology REM Sleep Behavior Disorder Stimulant anxiolysis (emotion) |
| Content Type | Text |
| Resource Type | Article |
